RSV: On the verge of change

After decades of failed attempts, the respiratory syncytial virus (RSV) treatment and vaccine landscape is on the verge of profound change.

RSV: On the verge of changeSeveral pharmaceutical companies have an RSV vaccine or preventative treatment in late-stage clinical trials – demonstrating highly promising results – and are racing to become the first to market.

In this short article, we highlight some of the key developments in this area, potential knowledge gaps and considerations for the future.

Download the full paper

For more on this topic, check out our latest update (March 2023) here.

Download

The author(s)

Related news

  • [WEBINAR] KEYS: The Year in Review
    Consumers Webinar

    [WEBINAR] KEYS: The Year in Review

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • Automotive Disruption and Trends Webinar
    Consumers Events replay

    Automotive Disruption and Trends Webinar

    Revisit Ipsos and SAA for a discussion on the future of mobility based on insights from the 2025 Ipsos Navigator Study.
  • Obesity Week
    Public Health Event

    Obesity Week

    This is a conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.